Researchers continue to excited about the medication , a groundbreaking dual agonist showing significant outcomes in clinical trials for size reduction . It acts by modulating two pathways : GLP-1 and https://abelgthv347445.dailyblogzz.com/41259298/the-new-prospect-for-weight-management